GL Sciences HPLC Columns for USP Methods

HPLC Columns for USP Methods

|

Analytical Precision and Regulatory Method Validation

 

GL Sciences HPLC Columns for USP Methods

The technical reliability of these columns is supported by rigorous batch-to-batch reproducibility testing. For regulated environments, GL Sciences offers "validated" versions of their most popular phases, which undergo additional quality control to ensure that retention times and selectivity remain constant over long-term projects.

 

These columns are available in various particle sizes ranging from 1.9 µm for UHPLC to 5 µm for conventional HPLC, providing the flexibility to modernize USP methods according to General Chapter <621> guidelines. By utilizing ultra-inert surface chemistry, these columns prevent non-specific adsorption, ensuring that pharmaceutical assays meet system suitability requirements for plate count and tailing factors across a wide pH range.

 

Compliance with USP L1 Classification for C18 Phases

The USP L1 code designates octadecyl silane chemically bonded to porous silica. GL Sciences offers a wide selection of L1 columns, ranging from the classic first-generation phases to the ultra-inert modern series. Technically, these columns are the first choice for the majority of USP monographs due to their high carbon loading and efficient end-capping. The high-purity silica base prevents the tailing of basic drug molecules, ensuring that pharmaceutical labs achieve high theoretical plate counts and consistent resolution in reversed-phase separations.

 

Specialized L7 Octyl Silane Columns for Medium Hydrophobicity

Columns categorized under USP L7 feature octyl silane (C8) bonded to silica particles. These are technically ideal for separations where a C18 phase provides excessive retention. GL Sciences' L7 columns are engineered to maintain high surface coverage, providing excellent stability across a wide pH range. This ensures that pharmaceutical ingredients with moderate hydrophobicity elute with sharp peaks, meeting the system suitability criteria required for official purity and assay tests in drug manufacturing.

 

L11 Phenyl Phases for Alternative Selectivity

USP L11 columns utilize phenyl groups chemically bonded to silica. These phases provide a different separation mechanism  interactions, which is technically necessary for separating aromatic compounds and isomers that co-elute on C18 phases. GL Sciences' L11 columns are designed to be extremely inert, minimizing secondary silanol interactions. This makes them highly effective for the analysis of complex pharmaceutical mixtures where specific selectivity for phenyl-containing molecules is required by the monograph.

 

High-Inertness ES Silica for USP System Suitability

The base material for many GL Sciences USP columns is the ES (Evolved Surface) silica. Technically, this silica is synthesized to be ultra-pure, with negligible metal impurities. This inertness is crucial for meeting USP system suitability requirements, particularly the tailing factor (T). By reducing interactions between basic analytes and the silica surface, these columns deliver symmetrical peaks, which simplifies integration and improves the accuracy of quantification for both active ingredients and their related impurities.

 

Particle Size Versatility and Method Modernization

To support the modernization of USP methods under General Chapter <621>, GL Sciences provides columns in 2 µm, 3 µm, and 5 µm particle sizes. Technically, smaller particles provide higher efficiency and faster analysis times, allowing labs to convert long isocratic USP methods into high-throughput UHPLC protocols. The consistent chemistry across different particle sizes ensures that the selectivity remains the same during the scale-down process, facilitating easier method validation and transfer between R&D and QC laboratories.

 

Validated Column Series for Regulated Quality Control

For pharmaceutical quality control (QC), consistency is the most important technical parameter. GL Sciences offers "Validated" column versions where three separate lots of silica are tested to guarantee identical performance. These columns come with detailed certificates of analysis, ensuring that the critical separation of impurities is reproducible year after year. This technical assurance minimizes the risk of method failure during routine drug testing, making them the preferred choice for long-term stability studies.

 

Wide pH Stability for Alkaline Drug Analysis

Many pharmaceutical compounds are basic and require alkaline mobile phases for optimal retention and peak shape. GL Sciences' advanced C18 and C8 phases are technically stable up to pH 10.0 or higher. This pH resilience is achieved through a specialized bonding process that protects the silica skeleton from dissolution. This capability is vital for USP methods that specify high-pH buffers, allowing for consistent performance without the rapid loss of column efficiency or changes in retention time.

 

L20 Diol and L8 Amino Phases for Polar Compounds

For the analysis of sugars or highly polar drug substances, USP codes L20 (Diol) and L8 (Amino) are often specified. GL Sciences' Diol columns provide a hydrophilic surface that is technically excellent for both normal-phase and size-exclusion chromatography (SEC). Their Amino (NH2) columns are optimized for sugar analysis with high retentivity and stability. These specialized phases ensure that polar pharmaceutical analytes are separated with high precision, complementing the reversed-phase portfolio to cover all major pharmacopeial application areas.

 

Click here for more information about GL Sciences range of products